"FU/Cal" contains two main ingredients: 5-fluorouracil : Also known as 5-FU or Efudix, this drug has been used for many years as an effective treatment for solar keratoses and Bowen's disease
An older 2016 review examines topical Print Save Vectical Ointment Generic name: calcitriol (topical) [ kal-SIT-ree-ol-TOP-ik-al ] Brand name: Vectical Drug class: Topical antipsoriatics Medically reviewed by Philip Thornton, DipPharm
Ointment, 3 mcg/g
Save up to 80% instantly! Calcitriol topical has an average rating of 8
1 out of 10 from a total of 203 ratings on Drugs
For topical dosage form (ointment): For plaque psoriasis: Adults and children 7 years of age and older—Apply to the affected area of the skin 2 times a day in the
VECTICAL (calcitriol) Ointment 3 mcg/g is a vitamin D analog intended for topical application to the skin
Topical psoriasis treatments: Creams and shampoos
1)
Calcitriol Ointment is not for oral, ophthalmic or intravaginal use
The structural formula is: Calcitriol is a white or almost white crystalline solid
Do not use more than 200 grams (g) per week
CALCITRIOL OINTMENT - TOPICAL
It provides a greasy or oily base that aids in the delivery of the active ingredient, Calcitriol, for localized treatment
Age 7 years or older: Maximum 200 grams per week
Calcitriol (calcitriol) Ointment 3 mcg/g is a vitamin D analog intended for topical application to the skin
Wash and gently dry the affected area
arrow_drop_down
VECTICAL (calcitriol) Ointment 3 mcg/g is a vitamin D analog intended for topical application to the skin
Quoted prices are for cash-paying customers and are not valid with insurance plans
This product is available in the following dosage forms: All Drugs; Human Drugs; Animal Drugs Generic name: calcitriol topical
calcitriol topical increases levels of calcium gluconate by pharmacodynamic synergism
Either increases toxicity of the other by pharmacodynamic synergism
Adult: In patients undergoing chronic renal dialysis: Usual dose: Initially, 1-2 mcg 3 times weekly, approx every other day, depending on the severity of condition
Dosage adjustment, dosing interruption, or discontinuation may be required
Patients with known severe renal or liver impairment should not be treated with calcipotriol (see section 4